Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifts in Pediatric Respiratory Virus Trends After the COVID-19 Pandemic: Insights From a 12-Year Hospital-Based Study in South Korea.

International journal of pediatrics·2026
Same author

Social Isolation and Excessive Weight Gain in Infants: A Nationwide Cohort Study of 1.8 Million Infants.

Journal of paediatrics and child health·2026
Same author

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Clinical Efficacy and Safety of Intramuscular Injections of Autologous Total IgG in Patients With Chronic Spontaneous Urticaria: An Open-Label Prospective Pilot Trial.

Experimental dermatology·2026
Same author

Quality of Life Impairment in Patients With Chronic Cough: How Does It Compare to Other Chronic Conditions?

Allergy, asthma & immunology research·2026
Same author

Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR).

Allergy, asthma & immunology research·2026

Related Experiment Video

Updated: Jun 14, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.2K

The KAAACI Guidelines for Sublingual Immunotherapy.

Jin-Young Min1, Hye Mi Jee2, Hwa Young Lee3

  • 1Department of Otorhinolaryngology-Head & Neck Surgery, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.

Allergy, Asthma & Immunology Research
|January 23, 2024
PubMed
Summary

Sublingual immunotherapy (SLIT) is a key disease-modifying treatment for allergies like allergic rhinitis and asthma. This guideline offers expert insights into SLIT

Keywords:
Allergen immunotherapyguidelinesublingual immunotherapy

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K

Related Experiment Videos

Last Updated: Jun 14, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K

Area of Science:

  • Allergy and Immunology
  • Pharmacology

Background:

  • Allergen immunotherapy is the sole disease-modifying treatment for allergic conditions such as allergic rhinitis and asthma.
  • Sublingual immunotherapy (SLIT) is increasingly prescribed for allergies, gaining clinical traction as a viable alternative to subcutaneous immunotherapy.
  • Decades of research support SLIT's efficacy, safety, and well-defined mechanisms of action.

Purpose of the Study:

  • To provide an expert opinion on the use of sublingual immunotherapy (SLIT) in Korea.
  • To consolidate current evidence on SLIT's mechanisms, patient selection, available products, and safety/efficacy profiles.
  • To guide healthcare professionals in the practical application of SLIT for allergic diseases.

Main Methods:

  • Extensive literature review conducted by specialists in allergy, pediatrics, and otorhinolaryngology.
  • Development of a clinical guideline based on accumulated evidence and expert consensus.
  • Focus on practical aspects of SLIT, including product information and patient management.

Main Results:

  • SLIT is a well-established, safe, and effective treatment option for allergic rhinitis and asthma.
  • Evidence supports SLIT as an alternative to subcutaneous immunotherapy.
  • The guideline details specific SLIT products available in Korea and criteria for patient selection.

Conclusions:

  • Sublingual immunotherapy (SLIT) is a valuable therapeutic option for managing allergic diseases.
  • This guideline enhances understanding and practical application of SLIT for clinicians.
  • SLIT offers a disease-modifying approach with a favorable safety and efficacy profile.